Crossmark

Advances in antitumour therapy with oncolytic herpes simplex virus combinations

Crossref DOI link: https://doi.org/10.1007/s12672-024-01165-z

Published Online: 2024-07-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Xuejiao
License Information

Text and Data Mining valid from 2024-07-24

Version of Record valid from 2024-07-24
More Information

Article History

Received: 12 December 2023

Accepted: 16 July 2024

First Online: 24 July 2024

Declarations

:

: The authors declare no competing interests.